Sudo Biosciences Raises $37M Series A Financing to Advance Precision TYK2 Therapeutics

by Business Wire • 2022/09/28 • 0 Comments

MENLO PARK, Calif.--(BUSINESS WIRE)-- #SeriesA--Sudo Biosciences Raises $37M Series A Financing to Advance Precision TYK2 Therapeutics

← Global Retinal Surgery Devices Market Analysis Report 2022-2027: Major Company Profiles, Deals, Strategies, Growth Drivers and Recent Developments – ResearchAndMarkets.com

Ora, Inc. Launches the Ora EyecupTM, a Revolutionary Ophthalmic Research Technology at Eyecelerator 2022 →